Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karlyne M Reilly

Showing results (31-40 of 52) with videos related to

Pageof 6
Sort By:
Cancer Research Communications|February 16, 2026
BRAFV600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in MiceFrancesco Tomassoni-Ardori, Karlyne M Reilly, Colleen Barrick, et al.
Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2004
Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effectsKarlyne M Reilly, Robert G Tuskan, Emily Christy, et al.
The Oncologist|October 25, 2023
The Landscape of US and Global Rare Tumor Research Programs: A Systematic ReviewChristina Vivelo, Karlyne M Reilly, Brigitte C Widemann, et al.
Cancer Research|February 4, 2010
The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivoSutapa Banerjee, Jonathan N Byrd, Scott M Gianino, et al.
Cancer Research|January 7, 2006
An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse modelKarlyne M Reilly, Karl W Broman, Roderick T Bronson, et al.
Molecular Cancer Therapeutics|May 6, 2010
Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent mannerThomas J Turbyville, Demirkan B Gürsel, Robert G Tuskan, et al.
Human Pathology|May 29, 2017
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overviewMarkku M Miettinen, Cristina R Antonescu, Christopher D M Fletcher, et al.
Journal of Cancer Research and Clinical Oncology|May 3, 2024
Germline findings in cancer predisposing genes from a small cohort of chordoma patientsMargarita Raygada, Liny John, Anne Liu, et al.
Journal of the National Cancer Institute|November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the FutureKarlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
Pageof 6

Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
Cancer Research Communications|February 16, 2026
BRAFV600E Expression in c-Kit+ Interstitial Cells of Cajal Drives Gastrointestinal Stromal Tumor Formation in MiceFrancesco Tomassoni-Ardori, Karlyne M Reilly, Colleen Barrick, et al.
Neuro-Oncology|June 4, 2011
Control of proliferation in astrocytoma cells by the receptor tyrosine kinase/PI3K/AKT signaling axis and the use of PI-103 and TCN as potential anti-astrocytoma therapiesDemirkan B Gürsel, Yvette S Connell-Albert, Robert G Tuskan, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 21, 2004
Susceptibility to astrocytoma in mice mutant for Nf1 and Trp53 is linked to chromosome 11 and subject to epigenetic effectsKarlyne M Reilly, Robert G Tuskan, Emily Christy, et al.
The Oncologist|October 25, 2023
The Landscape of US and Global Rare Tumor Research Programs: A Systematic ReviewChristina Vivelo, Karlyne M Reilly, Brigitte C Widemann, et al.
Cancer Research|February 4, 2010
The neurofibromatosis type 1 tumor suppressor controls cell growth by regulating signal transducer and activator of transcription-3 activity in vitro and in vivoSutapa Banerjee, Jonathan N Byrd, Scott M Gianino, et al.
Cancer Research|January 7, 2006
An imprinted locus epistatically influences Nstr1 and Nstr2 to control resistance to nerve sheath tumors in a neurofibromatosis type 1 mouse modelKarlyne M Reilly, Karl W Broman, Roderick T Bronson, et al.
Molecular Cancer Therapeutics|May 6, 2010
Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent mannerThomas J Turbyville, Demirkan B Gürsel, Robert G Tuskan, et al.
Human Pathology|May 29, 2017
Histopathologic evaluation of atypical neurofibromatous tumors and their transformation into malignant peripheral nerve sheath tumor in patients with neurofibromatosis 1-a consensus overviewMarkku M Miettinen, Cristina R Antonescu, Christopher D M Fletcher, et al.
Journal of Cancer Research and Clinical Oncology|May 3, 2024
Germline findings in cancer predisposing genes from a small cohort of chordoma patientsMargarita Raygada, Liny John, Anne Liu, et al.
Journal of the National Cancer Institute|November 9, 2017
Neurofibromatosis Type 1-Associated MPNST State of the Science: Outlining a Research Agenda for the FutureKarlyne M Reilly, AeRang Kim, Jaishri Blakely, et al.
Pageof 6